Xilio Therapeutics CEO René Russo's 2022 pay falls 60% to $2.2M
Xilio Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 25, 2023
Xilio Therapeutics reported fiscal year 2022 executive compensation information on April 25, 2023.
In 2022, three executives at Xilio Therapeutics received on average a compensation package of $1.4M, a 61% decrease compared to previous year.
Average pay of disclosed executives at Xilio Therapeutics
René Russo, Chief Executive Officer, received $2.2M in total, which decreased by 60% compared to 2021. 60% of Russo's compensation, or $1.3M, was in option awards. Russo also received $307K in non-equity incentive plan, $575K in salary, as well as $6.7K in other compensation.
Martin Huber, President and Head of R&D, received a compensation package of $1.3M, which decreased by 61% compared to previous year. 45% of the compensation package, or $607K, was in option awards.
Salvatore Giovine, Chief Financial Officer, earned $693K in 2022, a 64% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2023.